Asimov, the synthetic biology company advancing the design and production of therapeutics, today announced the launch of the AAV Edge System, a comprehensive suite of tools for adeno-associated viral (AAV) gene therapy design and manufacturing.
AsimovSep 18 2024 Asimov, the synthetic biology company advancing the design and production of therapeutics, today announced the launch of the AAV Edge System, a comprehensive suite of tools for adeno-associated viral gene therapy design and manufacturing. The system provides gene therapy developers a single access point to an array of best-in-class tools to supercharge gene therapy development.
While gene therapy holds significant promise for treating otherwise intractable diseases, the field is grappling with challenges in safety, efficacy, manufacturability, and cost. These issues are exacerbated by a fragmented ecosystem where key technologies are siloed across service providers, each offering disparate solutions. This fragmentation leads to suboptimal therapeutic development.
Production system: Today's launch introduces Asimov’s transient transfection-based AAV manufacturing system—the first in a planned series of releases for AAV Edge. This platform features a clonal, suspension-adapted, GMP-banked HEK293 host cell line; an optimized two-plasmid system compatible across capsid serotypes; and model-guided process development to improve bioreactor performance, achieving unconcentrated titers up to E12 viral genomes per milliliter .
Our team has been on a roll – AAV Edge is our third launch in cell and gene therapy this year. The cost and safety of gene therapies is top of mind for many in the field, and we're driven to help our partners on both design and production to enable more of these powerful medicines to reach patients. This is Asimov’s latest application in programming biology, made possible by leveraging AI, synthetic biology, and bioprocess engineering.
Gene Therapy Genetic Cell Efficacy Manufacturing Synthetic Biology Therapeutics
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New evidence for benefits of transcatheter edge-to-edge repair in secondary tricuspid regurgitationTricuspid transcatheter edge-to-edge repair (T-TEER) significantly reduced the severity of secondary tricuspid regurgitation and improved quality of life after one year, according to research presented in a Hot Line session August 31 at ESC Congress 2024.
Read more »
Transcatheter edge-to-edge repair found non-inferior to surgery in patients with secondary mitral regurgitationThere was no difference in efficacy between transcatheter edge-to-edge repair (TEER) and surgery in patients with secondary mitral regurgitation (MR), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024. The findings are published in the New England Journal of Medicine.
Read more »
Bank holiday drunks could push ‘collapsing’ criminal justice system over the edgeFears for weekend crime wave with courts in 'chaos' and prison bosses warning of 'absolutely desperate' situation
Read more »
Exploring solutions for AAV R&DThis article from ACROBiosystems explores solutions for the research and development of AAV.
Read more »
Loch Ness 'micro-monster' discovered after using 'cutting-edge' toolsThe team deployed a state-of-the-art holographic camera to look at the many microscopic organisms that inhabit the body of water.
Read more »
First look at 'cutting edge' Glasgow health centre with oxygen and light therapyPhotographs of a new wellness centre in Glasgow have been shared, with Holon offering ice baths, oxygen tanks, red-light therapy, 99 per cent filtered air, and more.
Read more »